Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Pre-filled Syringe (solution for injection) 1 X 0.025 mg / 0.5 ml |
|
20279 | 20760, 20804, 20145 |
Related information
Dosage
RESTRICTED TO ADULTS AND CHILDREN OVER TWO YEARS OF AGE.
A single injection ensures protection. Revaccination should be performed every 3 years if the risk of exposure continues.
The vaccination schedule is the same for children and for adults.
Method of administration: Intramuscular or subcutaneous route.
Indications
Prevention of typhoid fever in adults and in children over 2 years of age, and especially: travellers to endemic areas, migrants, health care professionals and military personnel.
Contra-Indications
Known hypersensitivity to one of the vaccine’s components.
Special Precautions
Do not inject by the intravascular route: make sure the needle does not penetrate a blood vessel.
This vaccine protects against the risks of infection by Salmonella typhi but not against Salmonella paratyphi A or B.
This vaccine is not indicated in children under 2 years of age because of the risk of insufficient antibody response.
Vaccination should be postponed in case of fever, acute disease or progressive chronic disease.
Side Effects
The effects reported after vaccination are usually moderate and of short duration.
Common: local injection site reactions (pain, oedema, redness).
Rare: general reactions: fever, asthenia, cephalalgia, malaise, arthralgia, myalgia, nausea, abdominal pain.
Very rare: allergic reactions (pruritus, skin rash, urticaria).
Isolated cases of serum sickness and anaphylactoid reactions have been reported.
Drug interactions
This vaccine may be given together with other common vaccines (hepatitis A, yellow fever, diphtheria, tetanus, poliomyelitis, rabies, meningitis A + C and hepatitis B) during the same vaccination session.
Pregnancy and Lactation
Pregnancy: No relevant teratogenic data in animals are available.
Currently, no relevant clinical data are available to assess a potential teratogenic or foetotoxic risk of this vaccine when administered during pregnancy.
Because of the seriousness of the disease, and in case of high risk of exposure to typhoid fever, pregnancy is not a reason not to administer the vaccine.
Lactation: This vaccine may be used during lactation.
Overdose
Not applicable.
